| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| TIDMARSH GEORGE F (10% Owner) has filed a Form 4 on REVELATION BIOSCIENCES, INC.|
Txns:
| Bought 20,000 shares
@ $1.6, valued at
$32k
|
|
| 02/14/2022 |
SC 13D
| TIDMARSH GEORGE F reports a 14.1% stake in Revelation Biosciences Inc. |
| 02/10/2022 |
4
| TIDMARSH GEORGE F (10% Owner) has filed a Form 4 on REVELATION BIOSCIENCES, INC.|
Txns:
| Bought 1,000 shares
@ $2.54, valued at
$2.5k
Bought 30,000 shares
@ $2.5533, valued at
$76.6k
|
|
| 02/09/2022 |
4/A
| TIDMARSH GEORGE F (10% Owner) has filed a Form 4 on REVELATION BIOSCIENCES, INC.|
Txns:
| Bought 7,900 shares
@ $2.3109, valued at
$18.3k
Bought 42,100 shares
@ $2.6076, valued at
$109.8k
Bought 2,000 shares
@ $2.45, valued at
$4.9k
|
|
| 02/08/2022 |
4
| TIDMARSH GEORGE F (10% Owner) has filed a Form 4 on REVELATION BIOSCIENCES, INC.|
Txns:
| Bought 7,900 shares
@ $2.3109, valued at
$18.3k
Bought 42,100 shares
@ $2.6076, valued at
$109.8k
|
|
| 01/20/2022 |
3
| TIDMARSH GEORGE F (10% Owner) has filed a Form 3 on REVELATION BIOSCIENCES, INC. |
| 09/23/2019 |
4
| TIDMARSH GEORGE F (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Exercised 77,331 shares
@ $0
Exercised 73,960 shares
@ $0
Exercised 78,821 options to buy
@ $0.54, valued at
$42.6k
Exercised 75,385 options to buy
@ $0.54, valued at
$40.7k
|
|
| 04/17/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 2 shares
@ $6.09, valued at
$12.2
Granted 2 options to buy
@ $7.16, valued at
$14.3 |
|
| 04/02/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 94 shares
@ $5.47, valued at
$514.2
Granted 94 options to buy
@ $6.43, valued at
$604.4 |
|
| 03/19/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 195 shares
@ $6.49, valued at
$1.3k
Granted 195 options to buy
@ $7.64, valued at
$1.5k
|
|
| 03/04/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 261 shares
@ $4.85, valued at
$1.3k
Granted 261 options to buy
@ $5.7, valued at
$1.5k
|
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 174,000 options to buy
@ $5.99, valued at
$1M
|
|
| 01/17/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 874 shares
@ $5.74, valued at
$5k
Granted 874 options to buy
@ $6.75, valued at
$5.9k
|
|
| 01/09/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Bought 82 shares
@ $5.85, valued at
$479.7
Bought 287 shares
@ $5.85, valued at
$1.7k
Bought 98 shares
@ $5.85, valued at
$573.3
Bought 397 shares
@ $5.85, valued at
$2.3k
Bought 700 shares
@ $5.85, valued at
$4.1k
Bought 436 shares
@ $5.85, valued at
$2.6k
|
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 154 shares
@ $8.0155, valued at
$1.2k
Granted 154 options to buy
@ $9.43, valued at
$1.5k
|
|
| 12/17/2018 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 112 shares
@ $10.88, valued at
$1.2k
Granted 112 options to buy
@ $12.8, valued at
$1.4k
|
|
| 12/03/2018 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 100 shares
@ $12.2995, valued at
$1.2k
Granted 100 options to buy
@ $14.47, valued at
$1.4k
|
|
| 11/19/2018 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 97 shares
@ $12.665, valued at
$1.2k
Granted 97 options to buy
@ $14.9, valued at
$1.4k
|
|
| 11/01/2018 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 89 shares
@ $13.855, valued at
$1.2k
Granted 89 options to buy
@ $16.3, valued at
$1.5k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2018 |
5
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 5 on LA JOLLA PHARMACEUTICAL CO |
| 01/04/2018 |
4
| TIDMARSH GEORGE F (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $24.73, valued at
$309.1k
|
|
| 12/29/2017 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 25,000 options to buy
@ $32.47, valued at
$811.8k
|
|
| 12/13/2017 |
4
| TIDMARSH GEORGE F (President, CEO & Secretary) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 183,000 options to buy
@ $28.1, valued at
$5.1M
|
|
| 12/06/2017 |
3
| TIDMARSH GEORGE F (Director) has filed a Form 3 on Odonate Therapeutics, LLC |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|